Skip to main navigation Skip to search Skip to main content

Multimorbidity: Epidemiology and risk factors in the golestan cohort study, Iran a cross-sectional analysis

  • Batoul Ahmadi
  • , Masoomeh Alimohammadian
  • , Mehdi Yaseri
  • , Azam Majidi
  • , Majid Boreiri
  • , Farhad Islami
  • , Hossein Poustchi
  • , Mohammad H. Derakhshan
  • , Akabar Feizesani
  • , Akram Pourshams
  • , Christian C. Abnet
  • , Paul Brennan
  • , Sanford M. Dawsey
  • , Farin Kamangar
  • , Paolo Boffetta
  • , Alireza Sadjadi
  • , Reza Malekzadeh
  • Tehran University of Medical Sciences
  • American Cancer Society
  • University of Glasgow
  • National Institutes of Health
  • Icahn School of Medicine at Mount Sinai
  • Morgan State University

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

Advances in medicine and health policy have resulted in growing of older population, with a concurrent rise in multimorbidity, particularly in Iran, as a country transitioning to a western lifestyle, and in which the percent of the population over the age of 60 years is increasing. This study aims to assess multimorbidity and the associated risk factors in Iran. We used data from 50,045 participants (age 40-75 y) in the Golestan Cohort Study, including data on demographics, lifestyle habits, socioeconomic status, and anthropometric indices. Multimorbidity was defined as the presence of 2 or more out of 8 self-reported chronic conditions, including cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, gastroesophageal reflux disease, tuberculosis, and cancer. Multivariate logistic regression models were used to examine the associations between multiple different factors and the risk factors. Multimorbidity prevalence was 19.4%, with the most common chronic diseases being gastroesophageal reflux disease (76.7%), cardiovascular diseases (72.7%), diabetes (25.3%), and chronic obstructive pulmonary disease (21.9%). The odds of multimorbidity was 2.56-fold higher at the age of >60 years compared with that at <50 years (P<0.001), and 2.11-fold higher in women than in men (P<0.001). Other factors associated with higher risk of multimorbidity included non-Turkmen ethnicity, low education, unemployment, low socioeconomic status, physical inactivity, overweight, obesity, former smoking, opium and alcohol use, and poor oral health. Apart from advanced age and female sex, the most important potentially modifiable lifestyle factors, including excess body weight and opium use, and opium user, are associated with multimorbidity. Policies aiming at controlling multimorbidity will require a multidimensional approach to reduce modifiable risk factors in the younger population in developing countries alongside adopting efficient strategies to improve life quality in the older population.

Original languageEnglish
Pages (from-to)e2756
JournalMedicine (United States)
Volume95
Issue number7
DOIs
StatePublished - 2016

Fingerprint

Dive into the research topics of 'Multimorbidity: Epidemiology and risk factors in the golestan cohort study, Iran a cross-sectional analysis'. Together they form a unique fingerprint.

Cite this